SGLT2 inhibitors improve survival and renal outcomes in heart failure: Lancet Medha Baranwal16 Sept 2020 7:50 AM ISTFrance: Treatment with empagliflozin and dapagliflozin reduces all-cause mortality and improves renal outcomes in patients with heart failure with...
Zydus Cadila generic empagliflozin, linagliptin tablets get tentative USFDA nod Medical Dialogues Bureau10 Sept 2020 2:27 PM ISTZydus Cadila Ltd's medication contains a combination of Empagliflozin and Linagliptin, oral diabetes medicines that help control blood sugar levels.
ESC update: Empagliflozin Cuts risk of Hospitalization, CV Mortality in HFrEF: EMPEROR Hina Zahid29 Aug 2020 11:45 AM ISTSophia Antipolis, France - Empagliflozin is second SGLT2 inhibitor after dapagliflozin to show a significant benefit in the treatment of reduced...
Empagliflozin add on to insulin premix effectively lowers blood sugar in diabetes: Study Medha Baranwal25 Aug 2020 7:09 PM ISTTaiwan: The addition of SGLT2 inhibitor empagliflozin versus linagliptin for 24 weeks to premixed insulin provides better blood sugar...
Diabetes Management: Alembic Pharma gets tentative USFDA nod to Empagliflozin, Metformin Hydrochloride tablets Farhat Nasim20 July 2020 2:13 PM ISTThe tentatively approved Empagliflozin and Metformin Hydrochloride tablets are therapeutically equivalent to Synjardy tablets of Boehringer Ingelheim...
ADA 2020: Empagliflozin reduces insulin need in diabetes patients Medha Baranwal17 Jun 2020 8:36 PM ISTDelhi: Treatment with the SGLT2 inhibitor empagliflozin reduces dependency on insulin in patients with type 2 diabetes (T2D) and cardiovascular...
Zydus gets USFDA tentative nod for Empagliflozin and Metformin Hydrochloride Tablets Ruchika Sharma2 May 2020 3:41 PM ISTAhmedabad: Zydus Cadila has received tentative approval from the USFDA to market Empagliflozin and Metformin Hydrochloride Tablets, 5 mg/500 mg, 5...
